Results 181 to 190 of about 59,014 (262)
This review highlights changes relevant to pathologists in the updated multidisciplinary classification of interstitial pneumonias. Changes include expansion beyond idiopathic disease, subclassification as interstitial (fibrotic vs non‐fibrotic) and alveolar filling disorders, expansion to include additional patterns (e.g.
Andrew G Nicholson +7 more
wiley +1 more source
Myeloid/lymphoid neoplasm with FLT3 gene fusion: report of a case with a novel t(5;13)(q13;q12) SSBP2::FLT3 fusion. [PDF]
Cook JR +6 more
europepmc +1 more source
Inactivation of the Nrf2/Are pathway in AD leads to decreased antioxidant and anti‐inflammatory response and to the accumulation of beta‐amyloid (Aβ) plaques, resulting in cognitive failure. Treatment with Isoeugenol activates Nrf2, reversing these outcomes by promoting antioxidant response in neuronal cells (N2a) and by increasing the anti ...
Ana Silva +14 more
wiley +1 more source
Imported Pediatric Paragonimiasis in China: Two Cases From Zhaotong to Hangzhou. [PDF]
Huang Y, Huang M, Yang Y, Zhu G.
europepmc +1 more source
MicroRNA clustering in pediatric asthma reveals differential corticosteroid responsiveness. [PDF]
Yang M +8 more
europepmc +1 more source
Prognostic Role of EMR1 in Lymph Nodes and Primary Tumors of Colon Cancer Patients
This study evaluated the prognostic value of the eosinophil biomarker EMR1 in 121 colon cancer patients. While high EMR1 levels in primary tumors correlated with improved survival, elevated levels in regional lymph nodes predicted poor outcomes. Combining EMR1 with CXCL17 further identified high‐risk patients.
Tamer Roshdy +9 more
wiley +1 more source
Nonasthmatic Eosinophilic Bronchitis: An Overlooked Cause of Chronic Cough in Children. [PDF]
Al Dhouyani B, Abushahin A, Abu-Hasan M.
europepmc +1 more source
Dosing Interval Extension of Dupilumab in CRSwNP: Five‐Year Real World Outcomes
ABSTRACT Background Chronic rhinosinusitis with nasal polyps (CRSwNP) is a persistent, often Type 2‐mediated inflammatory disease that markedly impairs quality of life. While dupilumab provides rapid improvement, there is limited evidence on long‐term outcomes beyond 2 years, and the clinical impact of dosing‐interval extension remains unclear.
Nicholas J. Campion +15 more
wiley +1 more source
Systemic Corticosteroids in the Management of Sinonasal Disease: An Evidence‐Based Expert Review
ABSTRACT Background Chronic rhinosinusitis (CRS) is a prevalent, heterogeneous inflammatory disease associated with significant morbidity. Systemic corticosteroids (SCS) are commonly prescribed for their anti‐inflammatory effects, but cumulative exposure carries risks, including metabolic, cardiovascular, and skeletal complications.
Andrew Thamboo +28 more
wiley +1 more source

